Gilmore Neil O'neill - Net Worth and Insider Trading

Gilmore Neil O'neill Net Worth

The estimated net worth of Gilmore Neil O'neill is at least $978,819 dollars as of 2024-11-05. Gilmore Neil O'neill is the CEO of Editas Medicine Inc and owns about 313,724 shares of Editas Medicine Inc (EDIT) stock worth over $978,819. Details can be seen in Gilmore Neil O'neill's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilmore Neil O'neill has not made any transactions after 2024-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gilmore Neil O'neill

To

Gilmore Neil O'neill Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gilmore Neil O'neill owns 4 companies in total, including Sarepta Therapeutics Inc (SRPT) , Unity Biotechnology Inc (UBX) , and Aptinyx Inc (APTX) among others .

Click here to see the complete history of Gilmore Neil O'neill’s form 4 insider trades.

Insider Ownership Summary of Gilmore Neil O'neill

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2018-06-07 SVP & Chief Medical Officer
UBX Unity Biotechnology Inc 2020-12-10 director
APTX Aptinyx Inc 2021-10-19 director
LIMIT LIMIT 2024-09-04 director & CEO

Gilmore Neil O'neill Latest Holdings Summary

Gilmore Neil O'neill currently owns a total of 1 stock. Gilmore Neil O'neill owns 313,724 shares of Editas Medicine Inc (EDIT) as of September 4, 2024, with a value of $978,819.

Latest Holdings of Gilmore Neil O'neill

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EDIT Editas Medicine Inc 2024-09-04 313,724 3.12 978,819

Holding Weightings of Gilmore Neil O'neill


Gilmore Neil O'neill Form 4 Trading Tracker

According to the SEC Form 4 filings, Gilmore Neil O'neill has made a total of 4 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Editas Medicine Inc is the sale of 1,555 shares on September 4, 2024, which brought Gilmore Neil O'neill around $5,318.

Insider Trading History of Gilmore Neil O'neill

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gilmore Neil O'neill Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gilmore Neil O'neill Ownership Network

Ownership Network List of Gilmore Neil O'neill

No Data

Ownership Network Relation of Gilmore Neil O'neill

Insider Network Chart

Gilmore Neil O'neill Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Gilmore Neil O'neill is the SVP & Chief Medical Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Gilmore Neil O'neill made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .

In summary, during the past 3 months, insiders sold 5,985 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net purchase of 31,053 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Gilmore Neil O'neill Mailing Address

Above is the net worth, insider trading, and ownership report for Gilmore Neil O'neill. You might contact Gilmore Neil O'neill via mailing address: 215 First Street, Cambridge Ma 02142.